tiprankstipranks
Analyst Profile
Followed by 25 other investors
.
Jasper Hellweg

Jasper Hellweg

Argus Research
Wall Street Analyst
Ranked #1,631 out of 8,045 Analysts on TipRanks (#2,939 out of 21,519 overall experts)

Success Rate

54%
54 out of 100 Profitable Transactions

Average Return

9.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Jasper Hellweg's ratings since 2016 and opened each position for the duration of 1 Year:
54.00% of your transactions would have been profitable with an average return of 9.5%

Stock Rating Distribution

127Ratings
78.74% Buy
21.26% Hold
0.00% Sell
Distribution of Jasper Hellweg's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Moderna
(MRNA)
Rating Type:Buy
Dates:Aug 26, 2020 - Aug 26, 2021
Gain:467.80%
The most profitable rating made by Jasper Hellweg

Jasper Hellweg's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
First Solar
Aug 31, 2016
Hold
Downgraded
0.00%
1
~ATHN
Athenahealth
Jul 07, 2017
Hold
Initiated
0.00%
1
TSRO
Tesaro
Nov 28, 2017
Buy
Reiterated
0%
-44.50%
1
BIVV
Bioverativ Inc
Jan 24, 2018
Hold
Downgraded
100%
+82.10%
2
HAWK
Blackhawk Network
Apr 25, 2018
Hold
Downgraded
0.00%
1
Viatris
Mar 27, 2019
Buy
Reiterated
$32.00
(188.03% Upside)
0%
-48.45%
3
Pinterest
Aug 15, 2019
Buy
Upgraded
$40.00
(71.09% Upside)
100%
+8.30%
2
ManpowerGroup
Oct 30, 2019
Hold
Downgraded
0.00%
1
Ligand Pharma
Mar 24, 2020
Hold
Downgraded
0%
-37.37%
4
Perrigo Company
Apr 17, 2020
Hold
Downgraded
0%
-5.90%
3
List of latest recommendations made by Jasper Hellweg. Click to expand and see Jasper Hellweg's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More